limitation of treatment with cyclophosphamide to 8 weeks/course ( 2.5 mg/kg/day ) minimizes this side effect without greatly increasing the rate of relapse of the nephrotic syndrome in the first 2 years after therapy .
C0010583
cyclophosphamide
C0027726
nephrotic syndrome